|         |                                                                                                                                                                   |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Reported net sales totaled $1.3 billion, up 16.6 percent. Sales grew 23.3 percent in constant currency and adjusting for the extra week in the prior-year period. |

|         |                                                                                                                                                                                      |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | GAAP earnings from continuing operations doubled to $0.40 per diluted share. Non-GAAP adjusted earnings from continuing operations1 rose 8.5 percent to $0.51 per diluted share. |

|         |                                                                                                                               |
|---------|-------------------------------------------------------------------------------------------------------------------------------|
| • | Company reiterates fiscal 2017 guidance for adjusted earnings from continuing operations of $2.60 to $2.70 per diluted share. |

|         |                                                  |
|---------|--------------------------------------------------|
| • | Consumable dental supplies increased 0.9 percent |

|         |                                      |
|---------|--------------------------------------|
| • | Equipment sales improved 5.4 percent |

|         |                                                                                                                                                        |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Other services and products, primarily composed of technical service, parts and labor, software support services and office supplies, rose 1.3 percent |

----

|         |                                                         |
|---------|---------------------------------------------------------|
| • | Assumes stable North American and international markets |

|         |                                                     |
|---------|-----------------------------------------------------|
| • | Excludes the impact of additional share repurchases |

|         |                           |
|---------|---------------------------|
| • | Excludes new acquisitions |

|         |                                                                                                                                                                                    |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Excludes transaction-related costs, integration and business restructuring expenses and deal amortization (See Reconciliation of GAAP and Non-GAAP Financial Measures table below) |

|         |                                                                                          |
|---------|------------------------------------------------------------------------------------------|
| • | Includes $25 million step up in operating expense associated with the ERP implementation |

----

|                                                                   |
|-------------------------------------------------------------------|
|                                                                   |  |  |  |  |  |  |  |
| (Dollars in thousands, except EPS)                                |   |   |   |
|                                                              | Three Months Ended |
|                                                              | July 30, 2016 |   | August 1, 2015 |
| Net income from continuing operations - reported                  | $ | 38,906 |  |   | $ | 20,311 |  |
| Transaction-related costs                                         | 216 |  |   | 9,302 |  |
| Deal amortization                                                 | 6,637 |  |   | 4,612 |  |
| Integration and business restructuring expenses                   | 3,032 |  |   | 871 |  |
| Tax impact of repatriation of cash                                | — |  |   | 11,800 |  |
| Net income from continuing operations - adjusted                  | $ | 48,791 |  |   | $ | 46,896 |  |
|                                                              |   |   |   |
| Diluted earnings per share from continuing operations - reported  | $ | 0.40 |  |   | $ | 0.20 |  |
| Transaction-related costs                                         | — |  |   | 0.09 |  |
| Deal amortization                                                 | 0.07 |  |   | 0.05 |  |
| Integration and business restructuring expenses                   | 0.03 |  |   | 0.01 |  |
| Tax impact of repatriation of cash                                | — |  |   | 0.12 |  |
| Diluted earnings per share from continuing operations - adjusted* | $ | 0.51 |  |   | $ | 0.47 |  |

----

----

|                                                                                                        |
|--------------------------------------------------------------------------------------------------------|
|                                                                                                        |  |  |  |  |  |  |  |
|                                                                                                   | Three Months Ended |
|                                                                                                   | July 30, 2016 |   | August 1, 2015 |
|                                                                                                   |   |   |   |
| Net sales                                                                                              | $ | 1,332,436 |  |   | $ | 1,142,870 |  |
|                                                                                                   |   |   |   |
| Gross profit                                                                                           | 317,178 |  |   | 288,244 |  |
|                                                                                                   |   |   |   |
| Operating expenses                                                                                     | 251,762 |  |   | 226,067 |  |
|                                                                                                   |   |   |   |
| Operating income from continuing operations                                                            | 65,416 |  |   | 62,177 |  |
|                                                                                                   |   |   |   |
| Other expense, net                                                                                     | (7,798 | ) |   | (11,473 | ) |
|                                                                                                   |   |   |   |
| Income from continuing operations before taxes                                                         | 57,618 |  |   | 50,704 |  |
|                                                                                                   |   |   |   |
| Income taxes                                                                                           | 18,712 |  |   | 30,393 |  |
|                                                                                                   |   |   |   |
| Net income from continuing operations                                                                  | 38,906 |  |   | 20,311 |  |
| Net income from discontinued operations                                                                | — |  |   | 9,392 |  |
| Net income                                                                                             | $ | 38,906 |  |   | $ | 29,703 |  |
|                                                                                                   |   |   |   |
| Basic earnings per share:                                                                              |   |   |   |
| Continuing operations                                                                                  | $ | 0.41 |  |   | $ | 0.20 |  |
| Discontinued operations                                                                                | — |  |   | 0.10 |  |
|             Net basic earnings per share   | $ | 0.41 |  |   | $ | 0.30 |  |
|                                                                                                   |   |   |   |
| Diluted earnings per share:                                                                            |   |   |   |
| Continuing operations                                                                                  | $ | 0.40 |  |   | $ | 0.20 |  |
| Discontinued operations                                                                                | — |  |   | 0.10 |  |
|             Net diluted earnings per share | $ | 0.40 |  |   | $ | 0.30 |  |
|                                                                                                   |   |   |   |
| Shares:                                                                                                |   |   |   |
|    Basic                                                                                | 95,461 |  |   | 99,436 |  |
|    Diluted                                                                              | 96,090 |  |   | 100,162 |  |
|                                                                                                   |   |   |   |
| Dividends declared per common share                                                                    | $ | 0.24 |  |   | $ | 0.22 |  |
|                                                                                                   |   |   |   |
| Gross margin - reported                                                                                | 23.8 |  % |   | 25.2 |  % |
|                                                                                                   |   |   |   |
| Operating expenses as a % of net sales - adjusted                                                      | 17.7 |  % |   | 18.0 |  % |
| Adjustments1                                                                                           | 1.2 |  |   | 1.8 |  |
| Operating expenses as a % of net sales - reported                                                      | 18.9 |  % |   | 19.8 |  % |
|                                                                                                   |   |   |   |
| Operating income as a % of net sales - adjusted                                                        | 6.1 |  % |   | 7.2 |  % |
| Adjustments1                                                                                           | (1.2 | ) |   | (1.8 | ) |
| Operating income as a % of net sales - reported                                                        | 4.9 |  % |   | 5.4 |  % |
|                                                                                                   |   |   |   |
| Effective tax rate - adjusted                                                                          | 33.0 |  % |   | 34.4 |  % |
| Adjustments1                                                                                           | (0.5 | ) |   | 25.5 |  |
| Effective tax rate - reported                                                                          | 32.5 |  % |   | 59.9 |  % |
|                                                                                                   |   |   |   |
| 1 Refer to the press release for the definition of adjustments to reported results                |

----

|                                                                                                              |
|--------------------------------------------------------------------------------------------------------------|
|                                                                                                              |  |  |  |  |  |  |  |
|                                                                                                         | July 30, 2016 |   | April 30, 2016 |
|                                                                                                         | (Unaudited) |   |   |
| ASSETS                                                                                                       |   |   |   |
| Current assets:                                                                                              |   |   |   |
| Cash and cash equivalents                                                                                    | $ | 89,978 |  |   | $ | 137,453 |  |
| Receivables                                                                                                  | 719,218 |  |   | 796,693 |  |
| Inventory                                                                                                    | 799,176 |  |   | 722,140 |  |
| Prepaid expenses and other current assets                                                                    | 82,696 |  |   | 91,255 |  |
|            Total current assets                       | 1,691,068 |  |   | 1,747,541 |  |
| Property and equipment, net                                                                                  | 298,104 |  |   | 293,315 |  |
| Goodwill and other intangible assets                                                                         | 1,309,188 |  |   | 1,325,889 |  |
| Long-term receivables, net and other                                                                         | 200,907 |  |   | 154,059 |  |
|            Total assets                               | $ | 3,499,267 |  |   | $ | 3,520,804 |  |
|                                                                                                         |   |   |   |
| LIABILITIES AND STOCKHOLDERS' EQUITY                                                                         |   |   |   |
| Current liabilities:                                                                                         |   |   |   |
| Accounts payable                                                                                             | $ | 523,105 |  |   | $ | 566,253 |  |
| Other accrued liabilities                                                                                    | 187,336 |  |   | 226,582 |  |
| Current maturities of long-term debt                                                                         | 18,563 |  |   | 16,500 |  |
| Borrowings on revolving credit                                                                               | 108,000 |  |   | 20,000 |  |
|            Total current liabilities                  | 837,004 |  |   | 829,335 |  |
| Long-term debt                                                                                               | 1,016,184 |  |   | 1,022,155 |  |
| Other non-current liabilities                                                                                | 228,042 |  |   | 227,568 |  |
|            Total liabilities                          | 2,081,230 |  |   | 2,079,058 |  |
| Stockholders' equity                                                                                         | 1,418,037 |  |   | 1,441,746 |  |
|            Total liabilities and stockholders' equity | $ | 3,499,267 |  |   | $ | 3,520,804 |  |

----

|                        |
|------------------------|
|                        |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                   | July 30, 2016 |   | August 1, 2015 |   | TotalSalesGrowth |   | ForeignExchangeImpact |   | Animal HealthInternationalImpact |   | InternalGrowth |
| Three Months Ended     |   |   |   |   |   |   |   |   |   |   |   |
|                   |   |   |   |   |   |   |   |   |   |   |   |
| Consolidated net sales |   |   |   |   |   |   |   |   |   |   |   |
| Consumable             | $ | 1,076,221 |  |   | $ | 895,307 |  |   | 20.2 |  % |   | (2.0 | )% |   | 22.0 |  % |   | 0.2 |  % |
| Equipment and software | 160,946 |  |   | 153,483 |  |   | 4.9 |  |   | (0.4 | ) |   | — |  |   | 5.3 |  |
| Other                  | 95,269 |  |   | 94,080 |  |   | 1.3 |  |   | (0.7 | ) |   | (0.2 | ) |   | 2.2 |  |
| Total                  | $ | 1,332,436 |  |   | $ | 1,142,870 |  |   | 16.6 |  % |   | (1.7 | )% |   | 17.2 |  % |   | 1.1 |  % |
|                   |   |   |   |   |   |   |   |   |   |   |   |
| Dental                 |   |   |   |   |   |   |   |   |   |   |   |
| Consumable             | $ | 332,948 |  |   | $ | 358,052 |  |   | (7.0 | )% |   | (0.4 | )% |   | — |  % |   | (6.6 | )% |
| Equipment and software | 150,882 |  |   | 143,670 |  |   | 5.0 |  |   | (0.4 | ) |   | — |  |   | 5.4 |  |
| Other                  | 71,185 |  |   | 73,395 |  |   | (3.0 | ) |   | (0.3 | ) |   | — |  |   | (2.7 | ) |
| Total                  | $ | 555,015 |  |   | $ | 575,117 |  |   | (3.5 | )% |   | (0.4 | )% |   | — |  % |   | (3.1 | )% |
|                   |   |   |   |   |   |   |   |   |   |   |   |
| Animal Health          |   |   |   |   |   |   |   |   |   |   |   |
| Consumable             | $ | 743,273 |  |   | $ | 537,255 |  |   | 38.3 |  % |   | (3.0 | )% |   | 36.6 |  % |   | 4.7 |  % |
| Equipment and software | 10,064 |  |   | 9,813 |  |   | 2.6 |  |   | (0.2 | ) |   | — |  |   | 2.8 |  |
| Other                  | 9,294 |  |   | 10,229 |  |   | (9.1 | ) |   | (4.6 | ) |   | (1.7 | ) |   | (2.8 | ) |
| Total                  | $ | 762,631 |  |   | $ | 557,297 |  |   | 36.8 |  % |   | (3.0 | )% |   | 35.3 |  % |   | 4.5 |  % |
|                   |   |   |   |   |   |   |   |   |   |   |   |
| Corporate              |   |   |   |   |   |   |   |   |   |   |   |
| Other                  | $ | 14,790 |  |   | $ | 10,456 |  |   | 41.4 |  % |   | — |  % |   | — |  % |   | 41.4 |  % |
| Total                  | $ | 14,790 |  |   | $ | 10,456 |  |   | 41.4 |  % |   | — |  % |   | — |  % |   | 41.4 |  % |
|                   |   |   |   |   |   |   |   |   |   |   |   |

----

|                         |
|-------------------------|
|                         |  |  |  |  |  |  |  |
|                    | Three Months Ended |
|                    | July 30, 2016 |   | August 1, 2015 |
|                    |   |   |   |
| Operating income (loss) |   |   |   |
| Dental                  | $ | 60,295 |  |   | $ | 67,252 |  |
| Animal Health           | 14,829 |  |   | 12,972 |  |
| Corporate               | (9,708 | ) |   | (18,047 | ) |
| Total                   | $ | 65,416 |  |   | $ | 62,177 |  |
|                    |   |   |   |
| Other income (expense)  |   |   |   |
| Interest income         | $ | 1,295 |  |   | $ | 789 |  |
| Interest expense        | (10,162 | ) |   | (12,143 | ) |
| Other                   | 1,069 |  |   | (119 | ) |
| Total                   | $ | (7,798 | ) |   | $ | (11,473 | ) |

----

|                                                                                                                                                             |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                             |  |  |  |  |  |  |  |
|                                                                                                                                                        | Three Months Ended |
|                                                                                                                                                        | July 30, 2016 |   | August 1, 2015 |
|                                                                                                                                                        |   |   |   |
| Operating activities:                                                                                                                                       |   |   |   |
| Net income                                                                                                                                                  | $ | 38,906 |  |   | $ | 29,703 |  |
| Net income from discontinued operations                                                                                                                     | — |  |   | 9,392 |  |
| Net income from continuing operations                                                                                                                       | 38,906 |  |   | 20,311 |  |
| Adjustments to reconcile net income from continuing operations        to net cash provided by operating activities: |   |   |   |
|       Depreciation & amortization                                                                                         | 20,359 |  |   | 15,247 |  |
|       Non-cash employee compensation                                                                                          | 9,184 |  |   | 6,965 |  |
|       Change in assets and liabilities, net of acquired                                                                       | (141,228 | ) |   | (34,829 | ) |
| Net cash (used in) provided by operating activities- continuing operations                                                                                  | (72,779 | ) |   | 7,694 |  |
| Net cash used in operating activities- discontinued operations                                                                                              | — |  |   | (2,270 | ) |
| Net cash (used in) provided by operating activities                                                                                                         | (72,779 | ) |   | 5,424 |  |
| Investing activities:                                                                                                                                       |   |   |   |
|    Additions to property and equipment, net of disposals                                                                                     | (15,042 | ) |   | (17,064 | ) |
|    Acquisitions and equity investments                                                                                                       | — |  |   | (1,104,730 | ) |
|    Other investing activities                                                                                                                | 9,337 |  |   | — |  |
| Net cash used in investing activities- continuing operations                                                                                                | (5,705 | ) |   | (1,121,794 | ) |
| Net cash used in investing activities- discontinued operations                                                                                              | — |  |   | (54 | ) |
| Net cash used in investing activities                                                                                                                       | (5,705 | ) |   | (1,121,848 | ) |
| Financing activities:                                                                                                                                       |   |   |   |
|    Dividends paid                                                                                                                            | (24,197 | ) |   | (23,128 | ) |
|    Repurchases of common stock                                                                                                               | (25,000 | ) |   | — |  |
|    Proceeds from issuance of long-term debt, net                                                                                             | — |  |   | 988,400 |  |
|    Retirement of long-term debt                                                                                                              | (4,125 | ) |   | — |  |
|    Draw on revolver                                                                                                                          | 88,000 |  |   | — |  |
|    Other financing activities                                                                                                                | (506 | ) |   | (745 | ) |
| Net cash provided by financing activities                                                                                                                   | 34,172 |  |   | 964,527 |  |
| Effect of exchange rate changes on cash                                                                                                                     | (3,163 | ) |   | (8,923 | ) |
| Net change in cash and cash equivalents                                                                                                                     | $ | (47,475 | ) |   | $ | (160,820 | ) |